Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatmentMarie Villedieu, Laurent Poulain|Gynecologic Oncology|2006Cited by 53
The anticancer effect of the <scp>HDAC</scp> inhibitor belinostat is enhanced by inhibitors of Bcl‐ <scp> x <sub>L</sub> </scp> or Mcl‐1 in ovarian cancerCécilia Thomine, Marie Villedieu|Molecular Oncology|2025Cited by 3